Skip to main content
Donate
Login
IASLC's 50th Anniversary
IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
2023 Annual Report
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2023 Highlights
Research & Education
Research & Education
Publications, Resources & Guidelines
Publications, Resources & Guidelines
Guide to COVID-19 and Lung Cancer
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 2017 - 2028 items out of 2110 results
ILCN article
US FDA Approves Frontline Amivantamab Combination for Patients with EGFR exon 20 Insertion-mutated NSCLC
Meeting
3rd International Summit on Lung Cancer
Webinar
Best of TTLC 2024
Meeting
2024 IASLC CT Screening Symposium
Podcast
ELCC 2024 Highlights
ILCN article
Regulating Artificial Intelligence
ILCN article
Experts Debate Addition of Frontline Chemotherapy for EGFR+ NSCLC
ILCN article
Should Biomarkers Be Used in the Clinical Management of ES-SCLC?
ILCN article
US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR
ILCN article
In Case You Missed It: IASLC Launches New Education Center
Meeting
2024 Masters in Thoracic Oncology Summit
Podcast
FDA Approval: FLAURA2, First Line Osimertinib Plus Chemotherapy for EGFR NSCLC
Pagination
First
First page
‹
Previous page
…
165
166
167
168
169
170
171
172
173
…
›
Next page
Last
Last page